p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

Robert J. Ihry(Novartis (United States)), Kathleen A. Worringer(Novartis (United States)), Max R. Salick(Novartis (United States)), Elizabeth Frias, Daniel Ho(Novartis (United States)), Kraig M. Theriault(Novartis (United States)), Sravya Kommineni(Novartis (United States)), Julie Chen, Marie Sondey(AbbVie (United States)), Chaoyang Ye(Blueprint Medicines (United States)), Ranjit Randhawa(Novartis (United States)), Tripti Kulkarni(Novartis (United States)), Zinger Yang, Gregory McAllister, Carsten Russ, John Reece-Hoyes, William C. Forrester, Gregory R. Hoffman, Ricardo Dolmetsch(Novartis (United States)), Ajamete Kaykas(Novartis (Switzerland))
Nature Medicine
June 8, 2018
Cited by 1,010

Abstract


Related Papers

No related papers found

Powered by citation graph analysis